TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.

D Currow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.